Clinical GFR Calculator (eGFR)
Calculate Glomerular Filtration Rate using the official 2021 Race-Free CKD-EPI, Cystatin C, MDRD, and Schwartz Pediatric equations with KDIGO staging.
🩺 Clinical Diagnosis & Meaning
Your estimated filtration rate indicates normal kidney function.
Estimated Functional Capacity: 95-100%
📋 Clinical Recommendations & Care Plan
- Routine annual checkup with primary care physician.
- Maintain target blood pressure (< 120/80 mmHg).
- Stay well hydrated and maintain low-sodium diet (< 2,000 mg/day).
KDIGO Chronic Kidney Disease Risk & Prognosis Matrix
Composite prognosis grading based on eGFR (G-Stage) and Albuminuria (A-Stage).
| GFR Stage (mL/min/1.73m²) | Persistent Albuminuria Categories | ||
|---|---|---|---|
| A1: Normal (<30 mg/g) | A2: Micro (30–300 mg/g) | A3: Severe (>300 mg/g) | |
| G1: Normal / High (≥90) | Low Risk | Moderate Risk | High Risk |
| G2: Mildly Decreased (60–89) | Low Risk | Moderate Risk | High Risk |
| G3a: Mild-Moderate (45–59) | Moderate Risk | High Risk | Very High Risk |
| G3b: Moderate-Severe (30–44) | High Risk | Very High Risk | Very High Risk |
| G4: Severely Decreased (15–29) | Very High Risk | Very High Risk | Very High Risk |
| G5: Kidney Failure (<15) | Very High Risk | Very High Risk | Very High Risk |
Cross-Formula Clinical Comparison
| Formula | Estimated Value | Clinical Context & Best Use |
|---|---|---|
| CKD-EPI 2021 (Creatinine) | -- mL/min/1.73m² | Current gold standard (NKF/ASN race-free guideline). |
| CKD-EPI 2021 (Creatinine + Cystatin C) | -- mL/min/1.73m² | Most accurate confirmatory marker for borderline cases. |
| MDRD Study Equation | -- mL/min/1.73m² | Historical standard; tends to underestimate GFR >60. |
| Cockcroft-Gault (CrCl) | -- mL/min | FDA drug dosing & pharmacokinetic adjustments. |
| CKD-EPI 2009 (Historical) | -- mL/min/1.73m² | Pre-2021 equation (includes legacy race coefficient). |
Understanding Your Glomerular Filtration Rate (eGFR)
The Glomerular Filtration Rate (GFR) is universally recognized by nephrologists and health organizations (including the National Kidney Foundation and KDIGO) as the single best overall measure of kidney function. It reflects the cumulative volume of blood filtered through the microscopic filters of the kidneys, known as glomeruli, each minute.
Why Was the 2021 Race-Free CKD-EPI Equation Created?
In 2021, the National Kidney Foundation (NKF) and the American Society of Nephrology (ASN) established a joint task force to re-evaluate the inclusion of race in GFR estimation. Previous equations (such as MDRD and CKD-EPI 2009) incorporated an automatic upward multiplier for Black individuals. Because race is a social rather than biological construct, this multiplier inadvertently delayed chronic kidney disease diagnoses, transplant evaluations, and access to specialized nephrology care.
The 2021 CKD-EPI equation eliminates race entirely while maintaining exceptional diagnostic accuracy across all patient demographics.
KDIGO Chronic Kidney Disease (CKD) Stages
| Stage | eGFR Range | Clinical Description | Primary Clinical Action |
|---|---|---|---|
| Stage 1 (G1) | ≥ 90 mL/min/1.73m² | Normal or high filtration (kidney damage present) | Manage blood pressure & blood sugar; annual monitoring. |
| Stage 2 (G2) | 60 – 89 mL/min/1.73m² | Mildly decreased kidney function | Cardiovascular risk reduction; review nephrotoxic medications. |
| Stage 3a (G3a) | 45 – 59 mL/min/1.73m² | Mild to moderately decreased | Evaluate complications (anemia, bone mineral disease); test uACR 2x/year. |
| Stage 3b (G3b) | 30 – 44 mL/min/1.73m² | Moderately to severely decreased | Nephrology consultation; dietary protein and electrolyte management. |
| Stage 4 (G4) | 15 – 29 mL/min/1.73m² | Severely decreased kidney function | Active preparation for kidney replacement therapy (dialysis/transplant). |
| Stage 5 (G5) | < 15 mL/min/1.73m² | Kidney failure (End-Stage Renal Disease - ESRD) | Renal replacement therapy initiation or conservative palliative care. |
Serum Creatinine vs. Cystatin C: When to Test Both?
While serum creatinine is the standard screening biomarker, it is a byproduct of muscle metabolism. Consequently, creatinine levels can be influenced by:
- High muscle mass (bodybuilders, athletes) or extreme muscle wasting (sarcopenia, cachexia, amputees).
- High dietary protein or creatine supplement intake.
- Liver cirrhosis or severe acute illness.
Cystatin C is an alternative filtration marker produced by all nucleated cells at a constant rate. KDIGO guidelines recommend measuring both Creatinine and Cystatin C (CKD-EPI cr-cys 2021) to confirm GFR when creatinine-based results are close to diagnostic thresholds (eGFR 45–59).
Frequently Asked Questions
Yes. eGFR can fluctuate based on hydration levels, acute dietary changes (eating cooked red meat before a blood draw), strenuous exercise, fever, or temporary medication effects (such as NSAIDs, ACE inhibitors, or diuretics). A diagnosis of CKD requires two abnormal tests spaced at least 90 days apart.
If the decline was caused by an acute kidney injury (such as severe dehydration, infection, or medication toxicity), eGFR can often return to baseline once the underlying issue is resolved. In chronic progressive CKD, while lost nephrons cannot regenerate, lifestyle modifications, blood pressure control, and newer medications (such as SGLT2 inhibitors and GLP-1 receptor agonists) can significantly slow or halt further progression.
eGFR measures true glomerular filtration adjusted to an average standard body surface area (1.73 m²). Creatinine Clearance (calculated via Cockcroft-Gault) estimates total creatinine excretion in mL/min and is primarily used by clinical pharmacists for FDA-approved drug dosing adjustments rather than disease staging.